Palmaz-Schatz stent for hepatic artery stenosis during hepatic arterial infusion chemotherapy.
Hepatic arterial infusion chemotherapy using an implantable port system was performed on a 40 year-old man with advanced hepatocellular carcinoma. When the in-dwelling catheter was inserted into the common hepatic artery (CHA), intimal dissection occurred as a result of the catheterization causing severe stenosis. On day 55 after intimal dissection, an in-dwelling Palmaz-Schatz stent was inserted after percutaneous transluminal angioplasty (PTA). CHA blood flow was shown to have improved on Digital subtraction angiography (DSA) and Doppler ultrasound after the in-dwelling Palmaz-Schatz stent. Thus a partial response was shown. The DSA from the implantable port system showed adequate patency 6 months after. This is the first report describing the usefulness of a Palmaz-Schatz stent for the severe stenosis of the CHA caused by the technique of catheterization.
Ogata
T
T
Department of Surgery, Kurume University Hospital, Fukuoka, Japan.
Okuda
K
K
Nagashima
J
J
Kinoshita
H
H
Nakayama
T
T
Aoyagi
S
S
Ichiki
K
K
Ueno
T
T
D000328:Adult; D015901:Angiography, Digital Subtraction; D000800:Angioplasty, Balloon; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002408:Catheters, Indwelling / Q000009:adverse effects*; D006499:Hepatic Artery / Q000000981:diagnostic imaging; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D015607:Stents
D000970:Antineoplastic Agents